Last update:

Alzheimer's disease & dementia news

Medical research

Dietary compound increases longevity and protects against Alzheimer's disease in experimental models

Researchers from the Color and Food Quality group at the Faculty of Pharmacy (University of Seville), in collaboration with Dr. Marina Ezcurra's group at the University of Kent (U.K.), have shown that the carotenoid phytoene ...

Alzheimer's disease & dementia

Questions over safety and effectiveness of new Alzheimer's drug

The safety and effectiveness of donanemab—an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA)—is called into question in an investigation published by The BMJ.

Genetics

Master copper regulator discovery may offer Alzheimer's clues

New therapeutic opportunities often emerge from research on simple organisms. For instance, the 2020 Nobel Prize in Chemistry awarded to Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., for their CRISPR-based DNA ...

Alzheimer's disease & dementia

Boosting brain protein levels may slow decline from Alzheimer's

A study published in the journal Brain shows that increases in protein levels with new Alzheimer's drugs can explain the slowing of cognitive impairment at least as well as the reduction in amyloid plaques.

Alzheimer's disease & dementia

Re-energizing mitochondria to treat Alzheimer's disease

Nerve cells in the brain demand an enormous amount of energy to survive and maintain their connections for communicating with other nerve cells. In Alzheimer's disease, the ability to make energy is compromised, and the connections ...

Alzheimer's disease & dementia

New tool helps predict progression of Alzheimer's

About 55 million people worldwide are living with dementia, according to the World Health Organization. The most common form is Alzheimer's disease, an incurable condition that causes brain function to deteriorate.

Alzheimer's disease & dementia

A type of dementia that hits the brains of men and women differently

Dementia is a brain disease that affects mental capacities such as the individual's memory, language, or capacity to understand and deal with emotions. Among the different types of dementia, dementia with Lewy bodies (DLB) ...

Medications

Study questions benefit of new Alzheimer's drug

Last summer, the U.S. Food and Drug Administration fully approved the first drug shown to slow the progress of Alzheimer's. But new research from the University of Georgia suggests that patients and caregivers may not experience ...

Neuroscience

Could bizarre visual symptoms be a telltale sign of Alzheimer's?

A team of international researchers, led by UC San Francisco, has completed the first large-scale study of posterior cortical atrophy, a baffling constellation of visuospatial symptoms that present as the first symptoms of ...

Alzheimer's disease & dementia

Understanding the impact of a dementia board game

Specialist dementia researchers from the University of Liverpool have seen positive initial findings when analyzing the outcomes of a board game that shines a light on dementia inequalities. Their paper, "Co-producing a boardgame ...

Neuroscience

Q&A: Researcher discusses tau and its role in Alzheimer's

The effects of Alzheimer's disease are devastating: not being able to recognize loved ones, losing precious memories, losing the ability to perform simple tasks, suffering through mood swings, and so on. Not only are memory ...

Alzheimer's disease & dementia

Flagging dementia patients for better hospital care

Cedars-Sinai investigators are using electronic health records to identify hospitalized patients likely to have dementia. The method they developed, detailed in a study published in the Journal of the American Geriatrics ...

Alzheimer's disease & dementia

'Exhausted' immune cells may drive Alzheimer's

Mice reach the twilight of their lives at around age two, the rough equivalent of 80 in human years. And when researchers introduce specific mutations into mice and then age them up, the mice can grow forgetful and irritable—eventually ...